Sanofi-Aventis suffers severe setback on US drug finding
179590
French pharmaceutical giant Sanofi-Aventis suffered a stinging stock market setback Thursday after a US panel said the company&#39;s obesity treatment was unsafe and should not be marketed in the United States.
31204
The story of COX-2 drugs is an example of how difficult it is for the F.D.A. to monitor the safety of drugs after they have been approved for the market.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
234695
SILVER SPRING, Maryland  - Sanofi-Aventis antibiotic Ketek should stay on the market but use should be limited to treating pneumonia, U.S. advisers said on Friday after reviewing rare cases of liver failure and other problems.
224422
New reports accuse another drug company of being too slow to pull a dangerous medication from the market and question the ability of the US federal Food and Drug Administration to protect Americans from such risks.
118423
Materials used by Abbott Laboratories to promote its HIV-fighting drug Kaletra overstate the medicine&#39;s effectiveness and fail to warn about risks in taking the drug, the US Food and Drug Administration said in a letter sent to the company.
54539
WASHINGTON - The US pharmaceutical industry that exports billions of dollars worth of medicine around the world faced new scrutiny Friday after a survey revealed nearly one-fifth of its government overseers had experienced pressure to approve drugs they
693013
A U.S. judge has granted a request from  Sanofi-Aventis and U.S. partner Bristol-Myers Squibb Co.   to block the sale in the United States of a generic  form of its top selling blood-thinner Plavix, giving a boost to  shares in the French drugmaker on Friday.
46542
Sanofi-Aventis is withdrawing its  application to sell obesity drug rimonabant -- its biggest new  drug hope -- in the United States, dealing a further blow to  its pipeline hopes.
701126
Sanofi-Aventis said on Friday it was  withdrawing its application to sell obesity drug rimonabant --  its biggest new drug hope -- in the United States.
39009
Novartis AG failed to give the government prompt, accurate reports about deaths of dogs treated with a painkiller in the same class of medicines now linked to heart problems in humans, US regulators have charged in a letter.
557
TRENTON, N.J. -- A federal court invalidated the patent yesterday for Merck &amp; Co.'s second-largest-selling drug, the blockbuster osteoporosis treatment Fosamax, in a decision that offers millions of patients hope for a cheaper version sooner, but darkens the company's already clouded outlook.
167015
PARIS/LONDON  - Sanofi-Aventis shares rose on   Friday after a U.S. judge blocked further sales of generic   Plavix, but gains were capped as it warned cheap supplies of   the blood-thinner already in the market would hit 2006 profits.
147347
A more cautious Food and Drug Administration dealt Procter &amp; Gamble a setback in its bid to be first to market a drug to improve women&#39;s sex drive.
550684
Sanofi-Aventis SA cut its 2006 earnings forecast Friday, warning that generic drug maker Apotex Corp. may have flooded the U.S. market with cheaper copies of the French company's blockbuster blood-thinning pill, Plavix.
109692
Contrary to what the product promises to do, the latest Viagra campaign has gone limp. According to US media reports, the US-based Food and Drug Administration has ordered drug major Pfizer to stop running
646800
Gaithersburg-based GenVec has run into a problem with its top drug candidate, and investors have had an adverse reaction. GenVec says the US Food and Drug Administration has requested that clinical trials